Wearable Vest Measures Lung Fluid to Guide Water Pill Dosing in Heart Failure
Tests a wearable vest that measures lung fluid in hospitalized adults with heart failure.
Plain-language title generated from the registry record
Registry title: Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure
Key facts
- Where
- San Francisco, United StatesSee the site
Where in United States
- University of California San FranciscoSan Francisco, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of California, San Francisco
- Trial code
- NCT03586336
- Record updated
- 2 September 2026
- Original description
This study evaluates the use of a wearable vest capable of non-invasively measuring lung fluid content in hospitalized patients with heart failureRead full original descriptionShow less
Remote Dielectric Sensing Technology Guided Diuresis in Hospitalized Patients With Acute Decompensated Heart Failure
This study evaluates the use of a wearable vest capable of non-invasively measuring lung fluid content in hospitalized patients with heart failure
Inclusion: Patients hospitalized for acute decompensated heart failure requiring treatment with intravenous diuretics and/or IV vasoactive drugs; Patient has signed informed consent and has authorized use and disclosed health information; Patient is at least 18 years of age; Patient physically suitable for ReDS measurement; GFR>25; Initial ReDS Measurement >35%.
Exclusion: Prior cardiac surgery within 2 months of index admission; Evidence of focal lung lesions on history, physical exam or chest x-ray, including history of pulmonary embolism, active pneumonia, or known lung nodule; Patient has a ventricular assist device or has had a cardiac transplantation; Congenital heart malformations or intra-thoracic mass that would affect right-lung anatomy (e.g dextrocardia, lung carcinoma, or pacemaker box in the right chest); Chronic renal failure (GFR<25); Patient characteristics excluded from approved use of ReDS system: height less than 155cm or greater than 190cm, BMI <22 or >39, chest circumference <80cm or >115cm , or flail chest; Patients in cardiogenic shock at admission requiring inotropic support.